Ropharma Bras (Romania) Performance
| RPH Stock | 0.17 0.01 6.25% |
The company holds a Beta of -0.44, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Ropharma Bras are expected to decrease at a much lower rate. During the bear market, Ropharma Bras is likely to outperform the market. At this point, Ropharma Bras has a negative expected return of -0.0373%. Please make sure to check Ropharma Bras' potential upside and the relationship between the accumulation distribution and price action indicator , to decide if Ropharma Bras performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ropharma Bras has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical indicators, Ropharma Bras is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Ropharma |
Ropharma Bras Relative Risk vs. Return Landscape
If you would invest 18.00 in Ropharma Bras on October 15, 2024 and sell it today you would lose (1.00) from holding Ropharma Bras or give up 5.56% of portfolio value over 90 days. Ropharma Bras is producing return of less than zero assuming 3.6035% volatility of returns over the 90 days investment horizon. Simply put, 32% of all stocks have less volatile historical return distribution than Ropharma Bras, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Ropharma Bras Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ropharma Bras' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ropharma Bras, and traders can use it to determine the average amount a Ropharma Bras' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0103
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RPH |
Estimated Market Risk
| 3.6 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ropharma Bras is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ropharma Bras by adding Ropharma Bras to a well-diversified portfolio.
About Ropharma Bras Performance
By examining Ropharma Bras' fundamental ratios, stakeholders can obtain critical insights into Ropharma Bras' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Ropharma Bras is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Ropharma Bras performance evaluation
Checking the ongoing alerts about Ropharma Bras for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ropharma Bras help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ropharma Bras generated a negative expected return over the last 90 days | |
| Ropharma Bras has some characteristics of a very speculative penny stock | |
| Ropharma Bras has high historical volatility and very poor performance |
- Analyzing Ropharma Bras' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ropharma Bras' stock is overvalued or undervalued compared to its peers.
- Examining Ropharma Bras' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ropharma Bras' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ropharma Bras' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ropharma Bras' stock. These opinions can provide insight into Ropharma Bras' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Ropharma Stock
Ropharma Bras financial ratios help investors to determine whether Ropharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ropharma with respect to the benefits of owning Ropharma Bras security.